ARMArm Holdings plc
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $0.15Missed
- vs $0.22 expected on Nov 4
- Stock move on it
- −17.67%
- two sessions around the report
- Typical move
- ±9.5%
- average over 2 reports
- Price
- $199.82
- −1.74% today · $240B cap
Past and upcoming reports
2
| Nov 4, 2026 | Sep 30, 2026 | Time not given | $0.22 | Missed$0.15 | −17.67%2d |
| Jul 29, 2026 | Jun 30, 2026 | Time not given | $0.40 | Beat$0.45 | −1.31%2d |
After the report
Jul 29, 2026 report
This covers the Jul 29, 2026 report. The Nov 4, 2026 numbers are in the table above.
ARM beats EPS estimates but stock slides 29% in month on valuation concerns
Arm Holdings reported Q2 FY2026 EPS of $0.45, beating consensus of $0.40 by 11.4%. Despite the beat, the stock has fallen ~29% in the past month, reflecting market skepticism over its extreme valuation (P/E 246x TTM, 110x forward). The sell-off indicates that even a strong print was insufficient to justify current multiples, especially with no explicit guidance to anchor future expectations.
Reported against expected
BeatEPS $0.45 vs. estimate $0.40, beat by 11.44% (surprise of $0.05).
Guidance
No explicit guidance was provided. the stock's post-print decline suggests the market viewed the beat as insufficient to validate current valuation levels.
How the stock reacted
Stock opened at $258.15, fell to close at $239.34 (-0.91% on the day). Down 28.97% over the past month.
What changed
EPS beat by 11.4%, but stock dropped 29% in a month on valuation fears.
What the price now assumes
Market is pricing that 110x forward earnings leave no room for error in AI monetization.
What it means for the business
Neutral bias. upgrade only if next quarter shows accelerating licensing revenue >25% YoY.
The next one to three months, as we saw it then
Better case25%
AI licensing ramps, driving revenue growth above 25% YoY and validating the premium multiple.
Base case45%
Growth continues around 22-24% YoY, but valuation compresses slowly as P/E adjusts to ~80x forward.
Worse case30%
AI capex slowdown or handset weakness causes a growth miss, triggering a sharp de-rating.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Enter only if stock falls below $200 or a major design win is announced. avoid if P/E remains above 100x without better growth visibility.
Scenario odds are a judgement, not measured.